Antiretroviral drug resistance in HIV-infected patients in Colombia

Soto-Ramirez, 2008, HIV/AIDS in Latin America, Science, 321, 465, 10.1126/science.1162896 UNAIDS/WHO. Epidemiological fact sheets on HIV and AIDS. Colombia; December 2008. Available at: http://www.who.int/globalatlas/predefinedReports/EFS2008/full/EFS2008_CO.pdf.(accessed July 2009). Departamento Administrativo Nacional de Estadistica (DANE), Columbia. Defunciones 2006. Available at: http://www.dane.gov.co/files/investigaciones/poblacion/defunciones/defun_2006/CUADRO5.xls.(accessed July 2009). Palella, 1998, Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators, N Engl J Med, 338, 853, 10.1056/NEJM199803263381301 Bennett, 2008, The World Health Organization's global strategy for prevention and assessment of HIV drug resistance, Antivir Ther, 13, 1, 10.1177/135965350801302S03 Jordan, 2008, World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites, Antivir Ther, 13, 15, 10.1177/135965350801302S07 Claims for HIV/AIDS treatment in Colombia jump more than 400 percent. AIDS Policy Law 2003; 18:8. Pan-American Health Organization (PAHO). Healthin the Americas. 2007 Edition. Washington, DC, USA, 2007. DiazGranados, 2007, Rate and predictors of optimal virologic response to antiretroviral therapy in Colombia, Int J Infect Dis, 11, 531, 10.1016/j.ijid.2007.03.002 Maglione M, Geotz M, Wang Z, Wagner G, HiltonL, Carter J, et al. Antiretroviral (ARV) drug resistance in the developing world. Evidence Report/Technology Assessment No. 156. Prepared by the Southern California Evidence-based Practice Center, under Contract No. 290-02-0003. AHRQ Publication No. 07-E014. Rockville, MD: Agency for Healthcare Research and Quality; 2007. Pillay, 2006, The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy. AIDS, 20, 21 Department of Health and Human Services, USA. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. November 3, 2008. Available at: http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf.(accessed July 2009). European AIDS Clinical Society. Guidelines for the clinical management and treatment of HIV infected adults in Europe. October 2008. Available at: http://www.europeanaidsclinicalsociety.org/guidelinespdf/1_Treatment_of_HIV_Infected_Adults.pdf.(accessed July 2009). Hammer, 2008, Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society USA panel, JAMA, 300, 555, 10.1001/jama.300.5.555 Ministerio de la Proteccion Social, Republica de Colombia. Guia para el manejo de VIH/SIDA, 2006. Available at: http://www.minproteccionsocial.gov.co/VBeContent/library/documents/DocNewsNo16914DocumentNo6250.pdf.(accessed July 2009). Olaya, 2006, Correlation and concordance of three HIV viral load techniques available in Colombia, Biomedica, 26, 302, 10.7705/biomedica.v26i2.1420 UNAIDS. [Colombia, progress report]. Available at: http://data.unaids.org/pub/Report/2008/colombia_2008_country_progress_report_es.pdf.(accessed July 2009). Eshleman, 2004, Performance of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for sequence-based analysis of diverse human immunodeficiency virus type 1 strains, J Clin Microbiol, 42, 2711, 10.1128/JCM.42.6.2711-2717.2004 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41(RR-17):1-19. Knobel, 2002, Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study, AIDS, 16, 605, 10.1097/00002030-200203080-00012 Brindeiro, 2003, Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals, AIDS, 17, 1063, 10.1097/00002030-200305020-00016 Delgado, 2001, Analysis of HIV type 1 protease and reverse transcriptase sequences from Venezuela for drug resistance-associated mutations and subtype classification: a UNAIDS study, AIDS Res Hum Retroviruses, 17, 753, 10.1089/088922201750237022 Soares, 2004, Primary HIV-1 drug resistance in Brazil, AIDS, 18, S9, 10.1097/00002030-200406003-00003 Rios, 2007, Antiretroviral drug resistance and phylogenetic diversity of HIV-1 in Chile, J Med Virol, 79, 647, 10.1002/jmv.20881 Lama, 2006, Linking HIV and antiretroviral drug resistance surveillance in Peru: a model for a third-generation HIV sentinel surveillance, J Acquir Immune Defic Syndr, 42, 501, 10.1097/01.qai.0000221677.29693.dd Dilernia, 2007, Drug-resistance surveillance among newly HIV-1 diagnosed individuals in Buenos Aires, Argentina, AIDS, 21, 1355, 10.1097/QAD.0b013e3280b07db1 Hirsch, 2008, Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society USA panel, Clin Infect Dis, 47, 266, 10.1086/589297 Ministerio de la Protección Social, República de Colombia. Modelo de gestión programática en VIH-SIDA. Available at: http://www.minproteccionsocial.gov.co/VBeContent/library/documents/DocNewsNo16914DocumentNo6251.pdf.(accessed July 2009). Descamps, 2005, French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002, J Acquir Immune Defic Syndr, 38, 545, 10.1097/01.qai.0000155201.51232.2e Sungkanuparph, 2007, Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails, Clin Infect Dis, 44, 447, 10.1086/510745 Poonpiriya, 2008, A study of seven rule-based algorithms for the interpretation of HIV-1 genotypic resistance data in Thailand, J Virol Methods, 151, 79, 10.1016/j.jviromet.2008.03.017 Carrion, 2003, Circulating recombinant form CRF02_AG in South America, AIDS Res Hum Retroviruses, 19, 329, 10.1089/088922203764969537 Navas, 1999, Analysis of the V3 loop sequences from 12 HIV type 1-infected patients from Colombia, South America, AIDS Res Hum Retroviruses, 15, 1141, 10.1089/088922299310430